MoRe® Life

Creating a better future for patients living with cardiovascular and orthopedic diseases.

vimeo-video-thumbnail

We are

MiRus leverages proprietary Rhenium-based alloy MoRe® to revolutionize medicine with safer, more durable implants and less invasive surgeries. Our integrated platform spans pre-operative, intra-operative, and post-operative solutions, offering innovative implant designs, novel procedural approaches, and advanced remote monitoring systems to enhance patient outcomes across the continuum of care.

Featured Product
ExpectMoreTag_mixed

Expect MoRe® with
Superior Biomaterials

MiRus' proprietary MoRe® alloy--made from Molybednum-Rhenium--ofers major advancement over traditional medical materials like titanium & cobalt chronium. Backed by over 15 years of R&D, MoRe® enables smaller, stronger, more durable implants with greater bicompatibility and significantly lower metal ion release. 

Recent News

MiRus Siegel™ TAVR US Early Feasibility Study (EFS) 30 Day Results Presented at NY Valves Meeting

ATLANTA, July 2, 2025 /PRNewswire/ -- The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, Piedmont Heart Institute, Atlanta and Raj R. Makkar MD, Cedars Sinai Heart Institute, Los Angeles presented...
Read More about MiRus Siegel™ TAVR US Early Feasibility Study (EFS) 30 Day Results Presented at NY Valves Meeting
Careers

Work With MiRus

At MiRus we give you the opportunity to develop your career based on your strengths and potential. MiRus is an early stage company with deep proprietary technology in both implants and procedural solutions. MiRus was started by a team of experienced entrepreneurs with a history of creating disruptive technologies and very successful, highly valued companies. 

Scroll to Top